IMPROVED ACCESS TO TECHNOLOGY NEEDED FOR PEOPLE WITH TYPE 2 DIABETES NEEDING INSULIN National Diabetes Services Scheme (NDSS) disparity in subsidised access to CGM systems
Australian Health Journal segment
Filmed in Canberra | March 2025
With
Susan Davidson, CEO
Australian Diabetes Educators Association
Sahar Awais,
NSW Registered Nurse
Susan Davidson is the CEO of the Australian Diabetes Educators Association (ADEA), the leading body for diabetes education in Australia. ADEA plays a crucial role in accrediting credentialed diabetes educators and providing essential training for all health professionals, as roughly 25% of individuals seeking healthcare are affected by diabetes.
In Australia, around 1.5 million people are diagnosed with diabetes, with an additional estimated 500,000 undiagnosed cases of Type 2 diabetes. Among those diagnosed, approximately 140,000 have Type 1 diabetes, while 1.3 million live with Type 2 diabetes, and about 65% of these individuals use insulin. The increasing prevalence of diabetes highlights the need for consistent education among healthcare providers to aid patients in managing their conditions effectively.
To address the evolving nature of diabetes management and technology, ADEA has recently introduced micro-credentials for healthcare professionals, enhancing their understanding of diabetes care. Consistent messaging from various healthcare providers is vital, as conflicting information can lead to patient confusion and disengagement from care.
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
Source: Rewritten from transcript
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
-
Pharmacist Prescribing Model gets further support from state health
A full scope pharmacist prescriber model allows pharmacists to independently prescribe medicines within their professional competence, without requiring prior doctor authorisation. It extends pharmacists’ role beyond dispensing to include assessment, diagnosis of minor and chronic conditions, initiation and modification of therapy, and ongoing patient monitoring. This model integrates pharmacists into primary care teams, aiming to improve timely access to treatment, reduce pressure on general practitioners, and enhance continuity of care. Pharmacists use their clinical knowledge, patient records, and collaborative pathways to ensure safe prescribing. The model emphasises training, regulation, and accountability to maintain high standards of patient safety.
-
Reporting on Australian childhood visual impairment: the first 10 years
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
